EMBRYONAL TUMOR WITH ABUNDANT NEUROPIL AND TRUE ROSETTES
Clinical trials for EMBRYONAL TUMOR WITH ABUNDANT NEUROPIL AND TRUE ROSETTES explained in plain language.
Never miss a new study
Get alerted when new EMBRYONAL TUMOR WITH ABUNDANT NEUROPIL AND TRUE ROSETTES trials appear
Sign up with your email to follow new studies for EMBRYONAL TUMOR WITH ABUNDANT NEUROPIL AND TRUE ROSETTES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with rare cancers: expanded access to DFMO drug
Disease control AVAILABLEThis study offers expanded access to the drug DFMO for children and young adults (ages 0-30) with rare, relapsed tumors like neuroblastoma and medulloblastoma. The drug targets tumors with specific genetic markers (LIN28, MYCN, or ODC). The goal is to provide treatment when no ot…
Matched conditions: EMBRYONAL TUMOR WITH ABUNDANT NEUROPIL AND TRUE ROSETTES
Sponsor: Giselle Sholler • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
New hope for toddlers with rare brain cancers: targeted chemo trial launches
Disease control Recruiting nowThis early-phase study tests whether adding a chemotherapy drug (topotecan) given directly into the spinal fluid, followed by maintenance chemo, is safe and feasible for children under 6 with high-risk embryonal brain tumors. About 15 children will participate. The goal is to see…
Matched conditions: EMBRYONAL TUMOR WITH ABUNDANT NEUROPIL AND TRUE ROSETTES
Phase: EARLY_PHASE1 • Sponsor: C17 Council • Aim: Disease control
Last updated May 12, 2026 13:48 UTC